Modern Medicine Now Top Story
New Jersey compounding pharmacy recalls all products, fearing mold contamination
Nine users for pharmacists to follow on Twitter
FDA documents compliance issues at 15 more compounding facilities
Information technology will drive innovation in healthcare, Kurzweil surmises
When attendees at the Ninth Annual Independent Pharmacy Business Growth Conference in Orlando, Fla. heard famed innovator Ray Kurzweil speak, they quickly realized Kurzweil is a man decades ahead of his time.
Walgreens completes purchase of regional drug store chain
The USA Drug pharmacy chain and its stores are now officially owned by Walgreens.
World AIDS Conference 2012 seeks an AIDS-free generation
This year's International AIDS Conference looked toward a generation free of AIDS.
FDA approves new treatment for a type of late-stage prostate cancer
FDA approved enzalutamide (Xtandi, Astellas Pharma U.S. Inc. and Medivation) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.
Strategies to combat online counterfeit drug supply
The National Association of Boards of Pharmacy issued a report last week that called for international collaboration among regulators and other public agencies to help combat the ongoing problem of the online counterfeit drug supply.
FDA warning: Counterfeit version of cancer drug Avastin circulating
Some cancer patients may not get proper treatment because a counterfeit version of the drug sold as Avastin 400mg/16mi has been purchased by as many as 19 medical practices in the United States, FDA warned Wednesday.